FDA Drug Recalls

Recalls / Class II

Class IID-0452-2023

Product

Unguentine Original Maximum Strength Pain Relieving/Antiseptic Ointment (Camphor 3.0%, Phenol 2.5%, Tannic Acid 2.2%, Oxide 6.6%), packaged in 1 oz. (28.3g) metal tubes, Distributed by: Oakhurst Company Levittown, NY 11756

Affected lot / code info
Lot #: 1E346A, Exp. Date Nov-23; 2E304A, Exp. Date Oct-24

Why it was recalled

CGMP DEVIATIONS

Recalling firm

Firm
Ecometics, Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
19 Concord St, Norwalk, Connecticut 06854-3706

Distribution

Distribution pattern
Nationwide within the United States

Timeline

Recall initiated
2023-02-24
FDA classified
2023-03-08
Posted by FDA
2023-03-15
Terminated
2023-06-21
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0452-2023. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: drug · FDA Drug Recalls